UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051451
Receipt number R000058676
Scientific Title Effect on blood glucose fluctuation after addition of imeglimin in patients with type 2 diabetes mellitus under pre-administration of metformin
Date of disclosure of the study information 2023/06/26
Last modified on 2023/06/27 09:18:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect on blood glucose fluctuation after addition of imeglimin in patients with type 2 diabetes mellitus under pre-administration of metformin

Acronym

Effect on blood glucose fluctuation after addition of imeglimin in patients with type 2 diabetes mellitus under pre-administration of metformin

Scientific Title

Effect on blood glucose fluctuation after addition of imeglimin in patients with type 2 diabetes mellitus under pre-administration of metformin

Scientific Title:Acronym

Effect on blood glucose fluctuation after addition of imeglimin in patients with type 2 diabetes mellitus under pre-administration of metformin

Region

Japan


Condition

Condition

Type 2 diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Additional administration of 2000 mg of imeglimin to type 2 diabetes patients receiving metformin, and verification of the efficacy of imeglimin using blood glucose fluctuation parameters

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Blood glucose fluctuation by CGM (Continuous Glucose Monitoring System)
TIR(Time in range)
TAR(Time above range)
TBR(Time below range)

Key secondary outcomes

Blood glucose fluctuation(Blood glucose,GMI,SD,CV,MAGE,CONGA2,MODD,Mvalue)
HbA1c,Body weight
BMI,Fasting blood glucose
Fasting CPR


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Imeglimin group

Interventions/Control_2

within the group

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Type 2 diabetes who have inadequate glycemic control(HbA1c between 7.0 and 12.4 %) under medical treatment by dieting and exercise cure and/or drug treatment.
2)Over 20 years old and less than 80 years old
3)Sex unquestioned
4)No treatment or treatment with stable doses of antihypertensive and antiplatelet agents for at least 3 months prior to randomization.
5)The patient who gives a written informed

Key exclusion criteria

1)Type 1 diabetes
2)Liver dysfunction (hepatic enzymes more than three times the upper limit of normal ranges)
3)A pregnant woman and/or a woman under breast-feeding
4)Impaired kidney function (serum crearinine greater than 1.3 mg/dl in men, 1.2 mg/dl in women)
5)Diabetic proliferative retinopathy
6)The patients who has an anamnesis of hypersensitivity to the ingredient of a trial drug
7)Patient with intolerance of medical reasons by doctor.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name teruo
Middle name
Last name jojima

Organization

Dokkyo Medical University

Division name

Department of Endocrinology and Metabolism

Zip code

321-0293

Address

880kita-kobayashi,Mibu,Tochigi321-0293,Japan

TEL

0282872150

Email

joima@dokkyomed.ac.jp


Public contact

Name of contact person

1st name Teruo
Middle name
Last name Jojima

Organization

Dokkyo Medical University

Division name

Department of Endocrinology and Metabolism

Zip code

321-0293

Address

880kita-kobayashi,Mibu,Tochigi321-0293,Japan

TEL

0282872150

Homepage URL


Email

jojima@dokkyomed.ac.jp


Sponsor or person

Institute

Dokkyo Medical University

Institute

Department

Personal name



Funding Source

Organization

Dokkyo Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Nasu red cross hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nasu red cross hospital

Address

1081-4 nakatahara, ootawara city, tochgi

Tel

0287-23-1122

Email

nrchp@nasu.jrc.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 06 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 11 Month 01 Day

Date of IRB

2022 Year 11 Month 08 Day

Anticipated trial start date

2023 Year 01 Month 04 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 06 Month 26 Day

Last modified on

2023 Year 06 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058676


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name